Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.
about
Melioidosis: epidemiology, pathophysiology, and management.Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogensProphylactic application of CpG oligonucleotides augments the early host response and confers protection in acute melioidosisRole of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge.The innate interferon gamma response of BALB/c and C57BL/6 mice to in vitro Burkholderia pseudomallei infection.Differential intracellular fate of Burkholderia pseudomallei 844 and Burkholderia thailandensis UE5 in human monocyte-derived dendritic cells and macrophages.CpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols.Immunospecific responses to bacterial elongation factor Tu during Burkholderia infection and immunization.Present and future therapeutic strategies for melioidosis and glanders.Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infectionCpG-modified plasmid DNA encoding flagellin improves immunogenicity and provides protection against Burkholderia pseudomallei infection in BALB/c miceA CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei.Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis.Cationic liposomes extend the immunostimulatory effect of CpG oligodeoxynucleotide against Burkholderia pseudomallei infection in BALB/c mice.The potential of antibody-mediated immunity in the defence against biological weapons.Intranasal prophylaxis with CpG oligodeoxynucleotide can protect against Yersinia pestis infection.Protection from pneumonic infection with burkholderia species by inhalational immunotherapyIntranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection.Monitoring Therapeutic Treatments against Burkholderia Infections Using Imaging TechniquesProtective response to subunit vaccination against intranasal Burkholderia mallei and B. pseudomallei challenge.Targeting the "cytokine storm" for therapeutic benefit.Melioidosis and glanders modulation of the innate immune system: barriers to current and future vaccine approaches.CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding.Burkholderia pseudomallei-induced expression of suppressor of cytokine signaling 3 and cytokine-inducible src homology 2-containing protein in mouse macrophages: a possible mechanism for suppression of the response to gamma interferon stimulationBacterial loads and antibody responses in BALB/c mice infected with low and high doses of Burkholderia pseudomallei.Intraperitoneal prophylaxis with CpG oligodeoxynucleotides protects neutropenic mice against intracerebral Escherichia coli K1 infection.
P2860
Q24522461-D73C5169-3A52-4AEA-BDCC-519BF7939BBDQ27011190-2A8EF665-D035-4BD7-AE95-C05E4CFDC7F3Q27305350-BD54AC88-F029-4CEC-8074-DED6D90A7DB9Q30424747-98ED722B-B1C3-4712-99E3-BBF119212169Q33254463-C387E5A7-FA43-4D1A-833D-80F9E3FC54DBQ33435686-E427495A-78EC-495F-9C9C-F820A43FBD1AQ33698285-FC7D70A3-1634-41C4-A8BD-7C6C0EAB9484Q33778331-6B3398E8-969B-4252-B6AD-46C07C793F68Q33797791-56327A42-76A2-4EC7-B581-E5F997A927DEQ33826261-3D75FE7C-F12F-4C0D-AC21-B714A8F90246Q34491695-6B249465-8EBB-44F1-B173-FAFAB39170D4Q34491754-AA4C8F52-BE28-4FDD-9CEE-B77684DDE8B7Q35129390-1C2A98C1-6685-47BF-988F-D312BE02016BQ35940681-48550930-2C71-4D38-9EC2-FD0472A0DB26Q36273411-6AF10DE6-DC1B-4129-B8FC-30A76C76FD4DQ36911486-0017E121-98B7-400F-83FD-266D7430A762Q37145069-5B9CE3F4-3184-42A2-8AA7-944CF03F5C3CQ37376858-1F845A0D-BF82-453F-8766-C32183F1FC6AQ37384332-3F9A35E0-CEB5-455D-B76B-CC689D6B352EQ37417238-D79BF2E3-1B96-4A89-BB33-A031B3C70E34Q38071254-B9F4F95C-D55B-4CCA-9ECE-3149687C6AF8Q38890754-2410517C-9D39-4215-9876-DC880B4BCEF9Q39182856-03C401F9-8292-4446-8D80-29FA23A8443CQ39392924-40C431C5-F62F-4AA3-8910-7D7EFCC7BB89Q40779856-DCD26063-8BD6-4CCA-A140-6A85C4668F43Q41900201-38A1DC77-A647-4363-BC3A-F2EB35C67A85
P2860
Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Immunostimulatory CpG oligodeo ...... ith Burkholderia pseudomallei.
@ast
Immunostimulatory CpG oligodeo ...... ith Burkholderia pseudomallei.
@en
type
label
Immunostimulatory CpG oligodeo ...... ith Burkholderia pseudomallei.
@ast
Immunostimulatory CpG oligodeo ...... ith Burkholderia pseudomallei.
@en
prefLabel
Immunostimulatory CpG oligodeo ...... ith Burkholderia pseudomallei.
@ast
Immunostimulatory CpG oligodeo ...... ith Burkholderia pseudomallei.
@en
P2093
P2860
P1476
Immunostimulatory CpG oligodeo ...... with Burkholderia pseudomallei
@en
P2093
Arthur M Krieg
Pakamas Intachote
Rasana W Sermswan
Sathit Pichyangkul
Stitaya Sirisinha
Wannapa Kespichayawattana
P2860
P304
P356
10.1128/IAI.72.8.4494-4502.2004
P407
P577
2004-08-01T00:00:00Z